“[Pharmacoeconomic Comparison Between Dupilumab and Tralokinumab for the Treatment of Atopic Dermatitis in Italy: A Cost-per-Responder Analysis]”, FE, vol. 26, no. 1, May 2025, doi: 10.7175/fe.v26i1.1571.